Related Experiment Video
Updated: Feb 26, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Glycemic control after metabolic surgery: a Granger causality and graph analysis.
Elena Previti1, Serenella Salinari1, Alessandro Bertuzzi2
1Department of Computer, Control, and Management Engineering "Antonio Ruberti," Sapienza University of Rome, Rome, Italy.
Malabsorptive metabolic surgery improved insulin sensitivity in obese and type 2 diabetic patients by altering hormonal pathways. Increased glucagon-like peptide-1 (GLP-1) and reduced gastric inhibitory polypeptide (GIP) are key factors in glucose homeostasis improvement.
Area of Science:
- Endocrinology and Metabolism
- Bariatric Surgery
- Diabetes Pathophysiology
Background:
- Nonesterified fatty acids (NEFA) negatively impact insulin secretion and are linked to diabetes development.
- Incretins, such as GLP-1 and GIP, play crucial roles in glucose regulation.
- Malabsorptive bariatric surgery, like biliopancreatic diversion (BPD), can induce steatorrhea and alter metabolic profiles.
Purpose of the Study:
- To investigate the roles of NEFA and incretins in insulin resistance and diabetes amelioration post-malabsorptive surgery.
- To analyze the dynamic changes in hormonal profiles and their interrelationships after BPD.
Main Methods:
- Studied healthy controls, obese subjects, and type 2 diabetic (T2D) subjects before and 1 month after BPD.
- Collected 24-hour plasma samples for glucose, NEFA, insulin, C-peptide, GLP-1, and GIP.
- Utilized Granger causality and graph analyses for time-course data; computed insulin sensitivity and secretion via oral glucose minimal model.
Main Results:
- Before surgery, NEFA levels significantly influenced other variables in obese and T2D subjects.
- Post-surgery, GLP-1 and C-peptide became central regulatory factors in obese and T2D subjects.
- BPD led to markedly reduced 24-hour GIP levels and completely normalized insulin sensitivity in both obese and T2D individuals.
Conclusions:
- Increased GLP-1 levels post-BPD positively impact glucose homeostasis in obese and T2D patients.
- Reduced plasma GIP levels also contribute to improved glucose metabolism in T2D patients after BPD.
- Targeting GIP reduction and GLP-1 increase pharmacologically may enhance glycemic control in T2D.
Related Concept Videos
Hypoglycemia and Glucagon
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Oral Hypoglycemic Agents: Glinides

